Doce-finding.
Top Line: What systemic agent do you use concurrent with definitive head and neck radiation for cisplatin-ineligible patients?
The Study: Despite this being a common problem, we still lack data demonstrating a clear winner. We know cetuximab is better than nothing and that durvalumab can’t stand up to cetuximab. While carboplatin remains an unchallenged contender, this phase 3 trial is here to throw docetaxel in the ring. It randomized 356 patients ineligible for cisplatin to definitive radiation alone versus concurrent with docetaxel 15 mg/m2 once weekly. The primary endpoint of disease-free survival at 2 years was significantly improved from 30% to 42% with the addition of docetaxel. What’s more, median overall survival was increased from 15 to 25 months and overall survival at 2 years from 40% to 50%. This all came at the cost of increased G3+ mucositis (22 → 50%), odynophagia (34 → 53%), and dysphagia (33 → 50%). Who’s up for a carbo versus docetaxel comparison..?
TBL: The addition of docetaxel concurrent to definitive head and neck radiation for cisplatin-ineligible patients significantly prolongs survival at the cost of more mucosal toxicity. | Patil, J Clin Oncol 2023
Hello Everyone
ReplyDeleteSelling SSN DOB Fullz in bulk
DL & work history will be include (if needed)
High Credit Scores USA Fullz/Pros
USA/UK/Canada CC Fullz also available
Dumps Tutorials & Dumps with pin codes available (101 & 202)
Business Fullz with EIN
Office365 Logs in bulk
Here I'm
TG/ICQ = @killhacks
WA = +92 317 2721122
Emails = exploit dot tools4u at gmail dot com
Wickr = peeterhacks
Hacking, Spamming, Carding Stuff also available
Tools with tutorials & Ebooks
Mailers/Brutes/Viruses
Kali Linux Full course
D**P/D**k web Courses with Legit Links
Combos/logs/I.P's/Proxies
Legit & Genuine Tools
Emails = exploit dot tools4u at gmail dot com
Wickr = peeterhacks
TG/ICQ = @killhacks
WA = +92 317 2721122